Andreas Seidl
Technik-/Wissenschafts-/F&E-Leiter bei FORMYCON AG
Aktive Positionen von Andreas Seidl
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FORMYCON AG | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 | - |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Geschäftsführer | 01.04.2019 | - |
Karriereverlauf von Andreas Seidl
Ausbildung von Andreas Seidl
Universität Konstanz | Doctorate Degree |
Statistik
International
Deutschland | 4 |
Operativ
Doctorate Degree | 1 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 2 |
Health Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FORMYCON AG | Health Technology |
Private Unternehmen | 1 |
---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
- Börse
- Insiders
- Andreas Seidl
- Erfahrung